Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12051
CALL
OFS Capital
OFS
$55.5M
| $64.6K | ﹤0.01% |
8,000
-6,500
| -45% | -$53.3K |
2022 Q1
11 quarters
|
|
12052
CALL
VanEck Agribusiness ETF
MOO
$1.14B
| $64.5K | ﹤0.01% |
1,000
-700
| -41% | -$49.7K |
2020 Q4
16 quarters
|
|
|
HUYA
12053
CALL
Huya Inc
HUYA
$525M
| $64.5K | ﹤0.01% |
21,000
-12,600
| -38% | -$44.7K |
2018 Q2
26 quarters
|
|
|
KLRS
12054
Kalaris Therapeutics
KLRS
$62.4M
| $64.5K | ﹤0.01% |
6,674
+3,013
| +82% | +$45.6K |
2023 Q4
4 quarters
|
|
12055
PUT
Bally's
BALY
$708M
| $64.4K | ﹤0.01% |
3,600
-14,000
| -80% | -$247K |
2022 Q4
8 quarters
|
|
|
JBIO
12056
PUT
Jade Biosciences
JBIO
$867M
| $64.4K | ﹤0.01% |
694
+668
| +2,569% | +$57.6K |
2024 Q2
2 quarters
|
|
12057
PUT
Amplitude
AMPL
$1.88B
| $64.4K | ﹤0.01% |
6,100
-2,600
| -30% | -$26K |
2021 Q4
12 quarters
|
|
12058
CALL
German American Bancorp
GABC
$1.81B
| $64.4K | ﹤0.01% |
1,600
+900
| +129% | +$38.1K |
2023 Q3
5 quarters
|
|
12059
PUT
Goosehead Insurance
GSHD
$1.04B
| $64.3K | ﹤0.01% |
600
-6,800
| -92% | -$742K |
2022 Q3
9 quarters
|
|
|
GATO
12060
CALL
DELISTED
Gatos Silver, Inc.
GATO
| $64.3K | ﹤0.01% |
4,600
-15,500
| -77% | -$252K |
2021 Q2
14 quarters
|
|
12061
PUT
Relay Therapeutics
RLAY
$3.99B
| $64.3K | ﹤0.01% |
15,600
-2,000
| -11% | -$10.9K |
2022 Q3
9 quarters
|
|
12062
SOPHiA GENETICS
SOPH
$624M
| $64.2K | ﹤0.01% |
20,586
+5,094
| +33% | +$17.3K |
2024 Q3
1 quarter
|
|
12063
PUT
Perma-Fix Environmental Services
PESI
$319M
| $64.2K | ﹤0.01% |
5,800
-1,200
| -17% | -$15.8K |
2023 Q1
7 quarters
|
|
12064
CALL
Timberland Bancorp
TSBK
$349M
| $64.1K | ﹤0.01% |
+2,100
| New | +$65.7K |
2024 Q4
0 quarters
|
|
12065
Fusion Fuel Green
HTOO
$15.9M
| $64K | ﹤0.01% |
+3,251
| New | +$58.9K |
2024 Q4
0 quarters
|
|
|
ELVA
12066
Electrovaya
ELVA
$306M
| $64K | ﹤0.01% |
+25,821
| New | +$60.4K |
2024 Q4
0 quarters
|
|
12067
PUT
Valens Semiconductor
VLN
$201M
| $64K | ﹤0.01% |
+24,600
| New | +$49.3K |
2024 Q4
0 quarters
|
|
12068
Aura Biosciences
AURA
$676M
| $63.9K | ﹤0.01% |
7,778
+6,767
| +669% | +$63.7K |
2021 Q4
12 quarters
|
|
|
AUTL
12069
PUT
Autolus Therapeutics
AUTL
$476M
| $63.9K | ﹤0.01% |
27,200
+26,400
| +3,300% | +$89.2K |
2023 Q4
4 quarters
|
|
12070
PUT
SkinHealth Systems
SKIN
$76.1M
| $63.9K | ﹤0.01% |
40,200
-194,000
| -83% | -$305K |
2021 Q1
15 quarters
|
|
|
WCLD
12071
CALL
WisdomTree Cloud Computing Fund
WCLD
$292M
| $63.8K | ﹤0.01% |
1,700
+200
| +13% | +$7.27K |
2021 Q1
15 quarters
|
|
12072
PUT
WSFS Financial
WSFS
$3.82B
| $63.8K | ﹤0.01% |
1,200
-3,300
| -73% | -$180K |
2024 Q3
1 quarter
|
|
12073
CALL
MarineMax
HZO
$1.16B
| $63.7K | ﹤0.01% |
2,200
-10,200
| -82% | -$313K |
2020 Q4
16 quarters
|
|
12074
CALL
HealthStream
HSTM
$985M
| $63.6K | ﹤0.01% |
2,000
| – | – |
2023 Q3
5 quarters
|
|
12075
CALL
Amalgamated Financial
AMAL
$1.41B
| $63.6K | ﹤0.01% |
1,900
+300
| +19% | +$10.3K |
2023 Q3
5 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.